Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Tech Master who wrote (654)	5/5/1998 10:54:00 AM
From: D.J.Smyth	Read Replies (3) \| Respond to of 2135

You may be correct Mr. Master; however, the telephone lines at the cancer institutes are ringing off the hook. this drug would most likely be brought to market faster than any other drug in history if it works; even if it works with a 40% probability of cure. people will demand nothing less. you've obviously never had cancer. at times lower price targets are given in order to load up on the shares in a panic sell. time will tell. and for these drugs time may be working in their favor, not against them. what think ye? what price can you put on public demands? (AZT for instance helped Glaxo Welcome to double)